Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Man Group PLC : Form 8.3 - Spectris plc
-
NextGen Signs LOI with Resi Labs to Scale AI Real Estate Subnet on Bittensor
-
AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE
-
Purpose Investments Inc. Announces Final October 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
Dynacor Group Declares November 2025 Dividend
-
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
-
Canada’s Seventh Costco Business Centre is now open in Mississauga
-
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
-
Morien Announces Advancement of the Lazy Head Aggregate Project in Nova Scotia
-
BLAQclouds Appoints Dr. Tony Ratliff to Its Advisory Board of Directors
-
ZenaTech’s ZenaDrone to Exhibit at Defense & Security 2025 in Bangkok and the Secure Australia Conference 2025 in Brisbane Expanding Asia-Pacific Defense Industry Relationships
-
Midland Continues to Discover New Gold Mineralization at the Caniapisc Au Project, James Bay
-
FG Nexus to Present at the 2025 ThinkEquity Conference
-
Polar received a Military contract to supply compact and light weight DC Generators for a mobile application
-
ZenaTech’s ZenaDrone to Exhibit at Defense & Security 2025 in Bangkok and the Secure Australia Conference 2025 in Brisbane Expanding Asia-Pacific Defense Industry Relationships
-
Lantronix Edge AI Technology Powers Sightline’s New AI-Driven Video Processor for Mission-Critical Drone Applications
-
Context Therapeutics to Participate in Upcoming Investor Conferences
-
Hubbell Reports Third Quarter 2025 Results
-
Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season
-
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc
-
Form 8.3 - Unite Group Plc
-
Authentrics.ai Accelerates Trusted AI at Scale and Is Now Available on Google Cloud Marketplace
-
Future Technologies Expands Leadership with Appointment of Mary Peterson as Chairperson of Advisory Board
-
Form 8.3 - AXA INVESTMENT MANAGERS: PRS REIT Plc
-
Shine, baby, shine: Solar energy is fuelling the energy transition at high speed
-
Form 8.3 - Empiric Student Property Plc
-
Unicycive Therapeutics Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End
-
Skyworks Reports Preliminary Q4 and Full Year FY25 Results
-
Skyworks and Qorvo to Combine to Create $22 Billion U.S.-Based Leader in High-Performance RF, Analog and Mixed-Signal Solutions
-
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
-
Abcourt obtains its environmental certificate of authorization for custom milling at the Sleeping Giant Mill
-
Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding the diversity of TPD medicines at the 8th Annual TPD & Induced Proximity Summit 2025
-
Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Diseases
-
Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025
-
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
-
Kaixin Holdings Announces Intended Acquisition of Honglu Technology to Optimize AI Applications
-
YourUpdateTV speaks with Mia Syn: FALL FAMILY RESET: EASY NUTRITION & LIFESTYLE STRATEGIES TO KEEP FAMILIES THRIVING ALL SEASON LONG
-
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
-
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025
-
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
-
AOI Announces Expansion in the City of Sugar Land
-
Americold Ireland Achieves Exclusive U.S. Meat Export Certification and Five AA-Rated Audits, Reinforcing Global Cold Chain Leadership
-
ONL Therapeutics Announces Randomization of First Patient in Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD
-
Koryx Copper Announces Further Positive Drill Results at the Haib Copper Project, Southern Namibia
-
Prospect Capital Corporation Announces Pricing of $167 Million 5.5% Oversubscribed Institutional Unsecured Notes Offering
-
Qorvo® Announces Preliminary Fiscal 2026 Second Quarter Financial Results
-
Laurette T. Koellner Rejoins Celestica’s Board of Directors
-
Chijet Motor Company Forges Transformative Exclusive Partnership with Singapore-Backed Tagvance to Pioneer Global Autonomous Driving Revolution
